Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value ($000): $130,473 (100.0% shares, 0.0% debt)

Holdings (11)

— ABIOMED INC 52.1%

Value ($000) $67,914 Shares 3,150,000 Est. Cost $21.56 Unrealized —

— ACURA PHARMACEUTICALS INC 14.3%

Value ($000) $18,713 Shares 10,294,886 Est. Cost $1.82 Unrealized —

— ENDOLOGIX INC 11.9%

Value ($000) $15,477 Shares 1,165,428 Est. Cost $13.28 Unrealized —

— HORIZON PHARMA INC 10.1%

Value ($000) $13,139 Shares 5,815,940 Est. Cost $2.26 Unrealized —

— ZIOPHARM ONCOLOGY INC 4.1%

Value ($000) $5,414 Shares 2,764,908 Est. Cost $1.96 Unrealized —

MNOV MEDICINOVA INC 2.4%

Value ($000) $3,078 Shares 1,170,370 Est. Cost $2.95 Unrealized 0.0%

— SOLTA MED INC 2.3%

Value ($000) $3,033 Shares 1,330,219 Est. Cost $2.28 Unrealized —

— CHINA CORD BLOOD CORP 2.2%

Value ($000) $2,915 Shares 1,037,690 Est. Cost $2.81 Unrealized —

— CURIS INC 0.6%

Value ($000) $745 Shares 233,797 Est. Cost $3.19 Unrealized —

— ECHO THERAPEUTICS INC 0.0%

Value ($000) $31 Shares 12,319 Est. Cost $2.52 Unrealized —

— PALATIN TECHNOLOGIES INC 0.0%

Value ($000) $14 Shares 23,928 Est. Cost $0.59 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	3,150,000	$67,914	52.1%	$21.56	—	COM	003654100
—	ACURA PHARMACEUTICALS INC	10,294,886	$18,713	14.3%	$1.82	—	COM NEW	00509L703
—	ENDOLOGIX INC	1,165,428	$15,477	11.9%	$13.28	—	COM	29266S106
—	HORIZON PHARMA INC	5,815,940	$13,139	10.1%	$2.26	—	COM	44047T109
—	ZIOPHARM ONCOLOGY INC	2,764,908	$5,414	4.1%	$1.96	—	COM	98973P101
MNOV	MEDICINOVA INC	1,170,370	$3,078	2.4%	$2.95	0.0%	COM NEW	58468P206
—	SOLTA MED INC	1,330,219	$3,033	2.3%	$2.28	—	COM	83438K103
—	CHINA CORD BLOOD CORP	1,037,690	$2,915	2.2%	$2.81	—	SHS	G21107100
—	CURIS INC	233,797	$745	0.6%	$3.19	—	COM	231269101
—	ECHO THERAPEUTICS INC	12,319	$31	0.0%	$2.52	—	COM NEW	27876L206
—	PALATIN TECHNOLOGIES INC	23,928	$14	0.0%	$0.59	—	COM PAR $ .01	696077403